thiamine pyrophosphate has been researched along with fluorodeoxyglucose f18 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, W; Chen, Z; Fei, G; Guan, Y; Jiao, F; Jin, L; Liu, H; Pan, S; Pan, X; Ren, S; Sang, S; Shi, H; Wang, C; Wang, Y; Yu, X; Zeng, F; Zhang, Y; Zhong, C; Zhou, W | 1 |
1 other study(ies) available for thiamine pyrophosphate and fluorodeoxyglucose f18
Article | Year |
---|---|
Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Brain; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Positron-Emission Tomography; Presenilin-1; Psychiatric Status Rating Scales; Thiamine; Thiamine Pyrophosphate; Thiazoles | 2018 |